# Comparative Evaluation of MEBO Ointment and Topical Diltiazem Ointment in the Treatment of Acute Anal Fissure

> **NCT04153032** · PHASE2 · RECRUITING · sponsor: **American University of Beirut Medical Center** · enrollment: 183 (estimated)

## Conditions studied

- Anal Fissure

## Interventions

- **DRUG:** Diltiazem
- **DRUG:** Mebo

## Key facts

- **NCT ID:** NCT04153032
- **Lead sponsor:** American University of Beirut Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-12-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-01-30
- **Target enrollment:** 183 (ESTIMATED)
- **Last updated:** 2025-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04153032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04153032, "Comparative Evaluation of MEBO Ointment and Topical Diltiazem Ointment in the Treatment of Acute Anal Fissure". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04153032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
